• Study of ranolazine in patients with ST-elevation heart attack and multiple blocked coronary arteries to improve small blood vessel function

    Recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Italy

  • Study of Mezagitamab in Adults with Primary IgA Nephropathy (Berger’s Disease) to Reduce Protein in Urine

    Recruiting

    3 1
    Austria Czechia France Germany Hungary Italy +6

  • Study of intravenous AOC 1001 to evaluate long-term safety and effectiveness in patients with myotonic dystrophy type 1

    Recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Denmark France Germany Italy The Netherlands Spain

  • Study of inhaled LTI-03 for safety and effectiveness in patients with Idiopathic Pulmonary Fibrosis who may be receiving standard antifibrotic therapy

    Recruiting

    2 1
    Investigated Diseases:
    Investigated Drugs:
    Germany Poland

  • Study of Janus kinase inhibitor dose reduction in patients with rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis who have achieved low disease activity

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    The Netherlands

  • Study of fixed-dose follitropin delta for ovarian stimulation in women undergoing intrauterine insemination treatment for infertility

    Recruiting

    2 1 1 1
    Investigated Drugs:
    France

  • Study of RO7837195 injection compared to placebo to treat moderate to severe ulcerative colitis

    Recruiting

    2 1
    Investigated Drugs:
    Czechia France Germany Italy Poland

  • Study of ivonescimab with chemotherapy combination for first and second-line treatment in patients with advanced or metastatic gastric and gastroesophageal cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    France

  • Study of metformin for cancer prevention in adolescents and adults with Li-Fraumeni syndrome

    Recruiting

    3 1 1 1
    Investigated Drugs:
    Germany

  • Study of patritumab deruxtecan versus drug combination in patients with hormone receptor-positive, HER2-negative advanced or metastatic breast cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    France Germany Greece Hungary Italy Poland +1

powered by